Lexicon Pharmaceuticals, Inc. (LXRX) Social Stream
LEXICON PHARMACEUTICALS INC (LXRX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering LEXICON PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-17 | 1 | $6 | $6 | $6 | $1.51 | 297.35% |
| 2022-06-13 | 1 | $5 | $5 | $5 | $1.51 | 231.13% |
| 2022-07-01 | 1 | $20 | $20 | $20 | $1.51 | 1224.5% |
| 2023-03-02 | 3 | $20 | $10 | $15 | $1.51 | 893.38% |
| 2023-05-02 | 4 | $20 | $3 | $11 | $1.51 | 628.48% |
| 2023-08-03 | 4 | $10 | $2.3 | $6.766 | $1.51 | 348.08% |
| 2023-08-05 | 4 | $10 | $2.3 | $5.766 | $1.51 | 281.85% |
| 2023-10-10 | 4 | $10 | $1.65 | $5.55 | $1.51 | 267.55% |
| 2023-11-08 | 4 | $10 | $1.45 | $5.483 | $1.51 | 263.11% |
The Trend in the Analyst Price Target
LXRX's average price target has moved down $3.52 over the prior 28 months.
Over the past 36 weeks, LXRX's average upside potential has been 330.04%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-02 | 3 | 20 | 3.00 | 11.000 | 2.38 | 362.18% |
| 2023-05-02 | 4 | 20 | 3.00 | 11.000 | 2.38 | 362.18% |
| 2023-05-31 | 4 | 10 | 3.00 | 7.000 | 3.30 | 112.12% |
| 2023-08-03 | 4 | 10 | 2.30 | 6.766 | 1.92 | 252.4% |
| 2023-10-10 | 4 | 10 | 1.65 | 5.550 | 1.12 | 395.54% |
LXRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 2 | 0 | 2 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 24 months, LXRX's average broker recommendation rating improved by 1.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, LEXICON PHARMACEUTICALS INC's variance in analysts' estimates is lower than -801.17% of them.
- LEXICON PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 1399.08% of all US stocks.
- In terms of how LEXICON PHARMACEUTICALS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 106.18% of that group.
- LEXICON PHARMACEUTICALS INC's average analyst price target is greater than 254.7% of Healthcare stocks.
Stocks similar to LEXICON PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ANIP, SIGA, and ASRT.
View All Top Stocks by Price Target
Is LXRX a Buy, Hold or Sell? See the POWR Ratings now!